Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.
Temasek
Activity from announced rounds
Temasek is a Singapore investment company with global public and private holdings, investing around digitisation, sustainable living, the future of consumption and longer lifespans.
Its global direct investments target both emerging and established market leaders. The four structural themes cut across industries: AI and computing, renewable energy and industrial decarbonisation, changing consumer demand and health-related innovation.
Temasek’s portfolio also includes Singapore-based companies and partnerships with fund managers. Since April 2026, its organisational structure separates global direct investments, Singapore holdings and partnership solutions, giving these distinct investment activities dedicated teams.
Sources
- Rounds participated in
- 11
- Confirmed lead rounds
- 2 5 roles undisclosed
- New companies
- 10 First participation on record · 1 follow-on
- Funding in participating rounds
- $22.3B 10 disclosed · full round size, not this investor’s share
By stage
By primary sector
3 more
By country
Rounds
11 in this selectionVinci develops AI systems designed to model physical behavior and help robots and other machines operate in real-world environments.
Devoted Health brings Medicare Advantage coverage together with medical care, virtual visits, in-home services and Member Service Guides for older adults.
The Boring Company builds tunnel-boring machines and underground Loop passenger systems for cities and transport partners.
Builds infrastructure for training and serving personally trainable AI agents
Provides open-standard AI networking infrastructure for ultra-low-latency training and inference
Provides a data security and AI governance platform helping enterprises control what AI can see and do
Produces lightweight, high-power, and safe next-generation lithium-ion batteries
Builds robotic intelligence for real-world environments using video-predictive control
Develops AI-driven drug discovery and oncology treatments
Waymo develops autonomous driving technology and operates a fully driverless ride-hailing service.